Literature DB >> 10667599

Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.

M P Shekhar1, J Werdell, L Tait.   

Abstract

Although there is experimental evidence supporting the involvement of angiogenesis in the pathogenesis of breast cancer, the exact nature and effects of interaction between human breast epithelial cells (HBECs) and endothelial cells (ECs) have not been described thus far. This approach requires an assay system that permits growth and differentiation of both epithelial and endothelial cells. Here, we report the development of a three-dimensional in vitro culture system that supports growth and functional differentiation of preneoplastic HBECs and ECs and recapitulates estrogen-induced in vivo effects on angiogenesis and the proliferative potential of MCF10AT xenografts. MCF10A and MCF10AT1-EIII8 (referred to as EIII8) cell lines used in this study are normal or produce preneoplastic lesions, respectively. When MCF10A or EIII8 cells are seeded on reconstituted basement membrane (Matrigel), both lines organize into a three-dimensional tubular network of cells; however, tubes produced by EIII8 cells appear multicellular in contrast to unicellular structures formed by MCF10A cells. However, when MCF10A or EIII8 cells are cocultured with human umbilical vein endothelial cells (HUVECs) on Matrigel, rather than interacting with extracellular matrix, the ECs exhibit preferential adherence to epithelial cells. Although both MCF10A and EIII8 cells provide preferential substrate for EC attachment, only EIII8 cells facilitate sustained proliferation of ECs for prolonged periods that are visualized as "endothelial cell enriched spots," which express factor VIII-related antigen. At regions of endothelial-enriched spots, preneoplastic HBECs undergo branching ductal-alveolar morphogenesis that produce mucin, express cytokeratins, and proliferating cell nuclear antigen. The presence of actively proliferating and functional endothelial cells is essential for ductal-alveolar morphogenesis of preneoplastic HBECs because without ECs, the epithelial cells formed only tubular structures. This ability to establish functional ECs and ductal-alveolar morphogenesis is facilitated only by preneoplastic HBECs because normal MCF10A cells fail to elicit similar effects. Thus, a cause-effect relationship that is mutually beneficial exists between EC and preneoplastic HBECs that is critical for generation of functional vascular networks and local proliferative ductal alveolar outgrowths with invasive potential. Both these processes are augmented by estrogen, whereas antiestrogens inhibit these processes. Induction and maintenance of angiogenic phenotype is associated with up-regulation in expression of interleukin 8 and matrix metalloproteinase-2 and estrogen-induced increases in vascular endothelial growth factor and vascular endothelial growth factor receptor 2. This three-dimensional culture model offers a unique opportunity to study endothelial- and epithelial cell-specific factors that are important for ductal-alveolar morphogenesis, angiogenesis, and progression to malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10667599

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Eph and ephrin signaling in mammary gland morphogenesis and cancer.

Authors:  Anne-Catherine Andres; Andrew Ziemiecki
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

Review 2.  The mammary gland vasculature revisited.

Authors:  Anne-Catherine Andres; Valentin Djonov
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-08-14       Impact factor: 2.673

3.  Hormone-responsive 3D multicellular culture model of human breast tissue.

Authors:  Xiuli Wang; David L Kaplan
Journal:  Biomaterials       Date:  2012-02-04       Impact factor: 12.479

4.  A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function.

Authors:  Xiuli Wang; Lin Sun; Maricel V Maffini; Ana Soto; Carlos Sonnenschein; David L Kaplan
Journal:  Biomaterials       Date:  2010-02-24       Impact factor: 12.479

5.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

6.  Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.

Authors:  Malathy P V Shekhar; Pratima Nangia-Makker; Larry Tait; Fred Miller; Avraham Raz
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.

Authors:  Yubo Zhai; Julia Santucci-Pereira; Ricardo Lopez de Cicco; Irma H Russo; Jose Russo
Journal:  Drug Discov Today Dis Mech       Date:  2012

8.  Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture.

Authors:  Saevar Ingthorsson; Valgardur Sigurdsson; Agla Fridriksdottir; Jon G Jonasson; Jens Kjartansson; Magnus K Magnusson; Thorarinn Gudjonsson
Journal:  BMC Res Notes       Date:  2010-07-07

9.  Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.

Authors:  Malathy P V Shekhar; Larry Tait; Robert J Pauley; Gen Sheng Wu; Steven J Santner; Pratima Nangia-Makker; Varun Shekhar; Hind Nassar; Daniel W Visscher; Gloria H Heppner; Fred R Miller
Journal:  Cancer Biol Ther       Date:  2008-11-12       Impact factor: 4.742

10.  Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity.

Authors:  Malathy P V Shekhar; Steven Santner; Kathryn A Carolin; Larry Tait
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.